WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Hits New 12-Month High – Still a Buy?

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY)’s stock price hit a new 52-week high on Wednesday. The stock traded as high as $14.38 and last traded at $14.33, with a volume of 20357 shares changing hands. The stock had previously closed at $13.66.

Analyst Ratings Changes

Separately, Zacks Research upgraded shares of WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has an average rating of “Hold”.

WuXi Biologics (Cayman) Trading Up 5.0%

The stock has a fifty day simple moving average of $11.97 and a 200 day simple moving average of $9.83.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology customers to support the development and production of biologic therapies, including monoclonal antibodies, recombinant proteins, vaccines and other complex biological products.

Its services span early-stage discovery and cell-line development through process development, clinical manufacturing, regulatory support and commercial-scale production.